Skip to main content

Home Redirect
About
- Management Team
- Board of Directors
Publications
- Publications
Investors
Contact Us

Home Redirect
About
- Management Team
- Board of Directors
Publications
- Publications
Investors
Contact Us

Press Releases

Normal

Press Release RSS Feed (opens in new window)

Press release year list 2021 2020 2019 2018 2017 2015

April 13, 2021

Avenue Therapeutics Announces that the FDA is Still Reviewing Its NDA Resubmission for IV Tramadol

Social

Investor Contact

Lucy Lu, M.D., CEO

ir@avenuetx.com

Email Alerts

To receive notifications via email, enter your email address and select at least one subscription below. After submitting your information, you will receive an email. You must click the link in the email to activate your subscription. You can sign up for additional subscriptions at any time.

* Required

Email Address *

Mailing Lists *

Press Release
SEC Filing
Presentation
Event
End of Day Stock Quote



Enter the code shown above.

Email Alert Sign Up Confirmation

Privacy
Disclaimer
Contact Us

Copyright © Avenue Therapeutics

Powered By Q4 Inc. 5.56.0.1 (opens in new window)